-
E-4031 for 3D hERG Electrophysiology
2026-09-15
E-4031 converts shell microelectrode arrays into a practical platform for linking hERG inhibition with three-dimensional repolarization, conduction, and arrhythmia-like activity. This workflow combines concentration-controlled pharmacology, field-potential mapping, and calcium corroboration to improve proarrhythmic substrate modeling in cardiac organoids.
-
CCK-8 Antagonism of Electroacupuncture Analgesia
2026-09-15
The 1986 reference study showed that central CCK-8 rapidly and dose-dependently counteracted electroacupuncture analgesia, while CCK-8 antiserum delayed or reversed electroacupuncture tolerance and morphine cross-tolerance. Its route-specific antagonist and antiserum experiments support a model in which prolonged electroacupuncture recruits endogenous CCK-8 as an anti-opioid signal rather than as a general regulator of nociception.
-
Novobiocin: From Mechanism to Translation
2026-09-14
Novobiocin is an aminocoumarin antibiotic with a strategically useful mechanistic range: bacterial DNA gyrase B inhibition, Hsp90 pathway disruption, and reported antiparasitic and antiviral activity. This article translates key piroplasm findings into practical assay design, selectivity assessment, resistance research, and translational decision-making.
-
Magneto-Piezoelectric Scaffolds for Bone Repair
2026-09-14
The ACS Nano study develops a dual-responsive scaffold that combines magnetic biofilm disruption with ultrasound-mediated activation of Icam1+ macrophages. Its central mechanistic finding is that the material promotes oxidative phosphorylation and reparative immune signaling through JAK2-STAT3 activation and MAPK-JNK suppression, improving regeneration in infectious bone defects.
-
Gepotidacin: Research Workflows & Assay Tips
2026-09-13
Gepotidacin, also known as GSK2140944, gives antibacterial research teams a mechanistically distinct probe for bacterial DNA replication inhibition and resistance studies. This guide translates clinical evidence into practical enzyme, susceptibility, DNA-damage, and troubleshooting workflows while keeping research use separate from medical application.
-
Affinity-Purified Goat Anti-Rabbit IgG Assays
2026-09-12
Discover how Affinity-Purified Goat Anti-Rabbit IgG (H+L) supports rigorous Western blot, ELISA, IHC, and ICC workflows. Using liver-fibrosis research as a case study, this guide connects HRP signal amplification with assay controls, mechanism validation, and reproducible interpretation.
-
Carfilzomib (PR-171): A Stress Map for Cancer Assays
2026-09-12
Carfilzomib (PR-171) is more than an irreversible proteasome inhibitor: it is a precision tool for mapping proteostasis failure, ER stress, and multiple cell-death phenotypes. This article translates recent ESCC radiation findings into practical assay-design decisions.
-
Lysis Buffer for Rapid Mouse Genotyping
2026-09-11
Streamline genomic DNA release from mouse tail, toe, or ear tissue with a lysis buffer designed for rapid genotyping workflows. This practical guide connects sample preparation, PCR troubleshooting, and model-quality control with insights from a colorectal cancer prognostic study.
-
Reactive Oxygen Species Assay Kit: DHE Workflow
2026-09-11
Build a controlled live-cell superoxide workflow for oxidative stress assay design, apoptosis research, and redox signaling studies. This guide translates findings on a glabridin–gold(I) complex into practical DHE readouts while separating relative ROS measurement from mechanistic proof.
-
Capsaicin Workflows for TRPV1 and KDM1A Studies
2026-09-10
Capsaicin is a versatile experimental probe for TRPV1 sensory biology, chronic dermatitis, pain–itch switching, and KDM1A/LSD1-linked cancer studies. This workflow-focused guide connects concentration selection, neuronal readouts, cell-based mechanism testing, and troubleshooting to improve reproducibility.
-
QPRT Drives Breast Cancer Invasion Through MLCK
2026-09-10
The reference study identifies quinolinate phosphoribosyltransferase (QPRT) as a metabolic determinant of breast cancer invasiveness and connects it to myosin light chain phosphorylation through purinergic, PLC, Rho/ROCK, and MLCK signaling. Its inhibitor-based and genetic experiments provide a mechanistic framework for studying how NAD-related metabolism can reshape actomyosin-dependent tumor cell motility.
-
Mucocutaneous Candidiasis: Diagnosis and Treatment
2026-09-09
This review establishes a practical diagnostic and treatment framework for mucocutaneous candidiasis, emphasizing direct microscopy, recognition of predisposing factors, and appropriately selected topical or systemic therapy. Its most useful contribution is the integration of clinical morphology, laboratory confirmation, disease classification, and treatment selection, including the role of Neticonazole Hydrochloride among topical imidazole agents.
-
ORM2–ZG16 Autophagy Axis in Pancreatic Fibrosis
2026-09-09
A 2026 Pancreatology study identifies ORM2 as an endogenous suppressor of chronic pancreatitis-associated fibrosis and connects its activity to ZG16-dependent autophagy control in pancreatic stellate cells. By combining pancreas-specific AAV perturbation, cell models, autophagic-flux assays, and protein-interaction analyses, the work provides a mechanistic framework for studying antifibrotic signaling.
-
Modified Ethanol Injection for mRNA Lipoplexes
2026-09-08
Tang and colleagues showed that a modified ethanol injection method can generate mRNA lipoplexes with strong expression in cell and mouse models, while identifying DC-1-16/DOPE/PEG-Chol as a particularly effective formulation. The work provides a practical carrier-screening framework for mRNA delivery and translation studies without relying on specialized microfluidic equipment.
-
Phenothiazines, ROS, and Macrophage Defense
2026-09-08
Qiu et al. report that phenothiazines strengthen macrophage antibacterial activity by increasing reactive oxygen species, lysosomal activity, and autophagy. Mechanistic inhibition experiments and an in vivo perphenazine model support a host-directed strategy for intracellular bacterial infections, while also defining important limits for translating class-level findings to individual compounds.